Metabolic Syndrome and β-Oxidation of Long-Chain Fatty Acids in the Brain, Heart, and Kidney Mitochondria

We present evidence that metabolic syndrome (MetS) represents the postreproductive stage of the human postembryonic ontogenesis. Accordingly, the genes governing this stage experience relatively weak evolutionary selection pressure, thus representing the metabolic phenotype of distant ancestors with...

Full description

Bibliographic Details
Main Authors: Alexander Panov, Vladimir I. Mayorov, Sergey Dikalov
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/23/7/4047
_version_ 1797438864038559744
author Alexander Panov
Vladimir I. Mayorov
Sergey Dikalov
author_facet Alexander Panov
Vladimir I. Mayorov
Sergey Dikalov
author_sort Alexander Panov
collection DOAJ
description We present evidence that metabolic syndrome (MetS) represents the postreproductive stage of the human postembryonic ontogenesis. Accordingly, the genes governing this stage experience relatively weak evolutionary selection pressure, thus representing the metabolic phenotype of distant ancestors with β-oxidation of long-chain fatty acids (FAs) as the primary energy source. Mitochondria oxidize at high-rate FAs only when succinate, glutamate, or pyruvate are present. The heart and brain mitochondria work at a wide range of functional loads and possess an intrinsic inhibition of complex II to prevent oxidative stress at periods of low functional activity. Kidney mitochondria constantly work at a high rate and lack inhibition of complex II. We suggest that in people with MetS, oxidative stress is the central mechanism of the heart and brain pathologies. Oxidative stress is a secondary pathogenetic mechanism in the kidney, while the primary mechanisms are kidney hypoxia caused by persistent hyperglycemia and hypertension. Current evidence suggests that most of the nongenetic pathologies associated with MetS originate from the inconsistencies between the metabolic phenotype acquired after the transition to the postreproductive stage and excessive consumption of food rich in carbohydrates and a sedentary lifestyle.
first_indexed 2024-03-09T11:44:27Z
format Article
id doaj.art-58de5b33e8d347d8a6e26d8dab3aa9f4
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-09T11:44:27Z
publishDate 2022-04-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-58de5b33e8d347d8a6e26d8dab3aa9f42023-11-30T23:25:59ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672022-04-01237404710.3390/ijms23074047Metabolic Syndrome and β-Oxidation of Long-Chain Fatty Acids in the Brain, Heart, and Kidney MitochondriaAlexander Panov0Vladimir I. Mayorov1Sergey Dikalov2Department of Biomedical Sciences, Mercer University School of Medicine, Macon, GA 31201, USADepartment of Biomedical Sciences, Mercer University School of Medicine, Macon, GA 31201, USADivision of Clinical Pharmacology, Vanderbilt University Medical Center, Nashville, TN 37232, USAWe present evidence that metabolic syndrome (MetS) represents the postreproductive stage of the human postembryonic ontogenesis. Accordingly, the genes governing this stage experience relatively weak evolutionary selection pressure, thus representing the metabolic phenotype of distant ancestors with β-oxidation of long-chain fatty acids (FAs) as the primary energy source. Mitochondria oxidize at high-rate FAs only when succinate, glutamate, or pyruvate are present. The heart and brain mitochondria work at a wide range of functional loads and possess an intrinsic inhibition of complex II to prevent oxidative stress at periods of low functional activity. Kidney mitochondria constantly work at a high rate and lack inhibition of complex II. We suggest that in people with MetS, oxidative stress is the central mechanism of the heart and brain pathologies. Oxidative stress is a secondary pathogenetic mechanism in the kidney, while the primary mechanisms are kidney hypoxia caused by persistent hyperglycemia and hypertension. Current evidence suggests that most of the nongenetic pathologies associated with MetS originate from the inconsistencies between the metabolic phenotype acquired after the transition to the postreproductive stage and excessive consumption of food rich in carbohydrates and a sedentary lifestyle.https://www.mdpi.com/1422-0067/23/7/4047metabolic syndromekidneyheartbrain mitochondriaβ-oxidationlong-chain fatty acids
spellingShingle Alexander Panov
Vladimir I. Mayorov
Sergey Dikalov
Metabolic Syndrome and β-Oxidation of Long-Chain Fatty Acids in the Brain, Heart, and Kidney Mitochondria
International Journal of Molecular Sciences
metabolic syndrome
kidney
heart
brain mitochondria
β-oxidation
long-chain fatty acids
title Metabolic Syndrome and β-Oxidation of Long-Chain Fatty Acids in the Brain, Heart, and Kidney Mitochondria
title_full Metabolic Syndrome and β-Oxidation of Long-Chain Fatty Acids in the Brain, Heart, and Kidney Mitochondria
title_fullStr Metabolic Syndrome and β-Oxidation of Long-Chain Fatty Acids in the Brain, Heart, and Kidney Mitochondria
title_full_unstemmed Metabolic Syndrome and β-Oxidation of Long-Chain Fatty Acids in the Brain, Heart, and Kidney Mitochondria
title_short Metabolic Syndrome and β-Oxidation of Long-Chain Fatty Acids in the Brain, Heart, and Kidney Mitochondria
title_sort metabolic syndrome and β oxidation of long chain fatty acids in the brain heart and kidney mitochondria
topic metabolic syndrome
kidney
heart
brain mitochondria
β-oxidation
long-chain fatty acids
url https://www.mdpi.com/1422-0067/23/7/4047
work_keys_str_mv AT alexanderpanov metabolicsyndromeandboxidationoflongchainfattyacidsinthebrainheartandkidneymitochondria
AT vladimirimayorov metabolicsyndromeandboxidationoflongchainfattyacidsinthebrainheartandkidneymitochondria
AT sergeydikalov metabolicsyndromeandboxidationoflongchainfattyacidsinthebrainheartandkidneymitochondria